Want to join the conversation?
$RHT expects FY16 revenue to be in the range of $2.034-2.044Bil and targets non-GAAP operating margin of 23.6%, cash flow to be in the range of $690-705MM, and diluted non-GAAP EPS to be in range of $1.85-1.87 per share. For 3Q16, $RHT expects revenue of $519-523MM, non-GAAP operating margin of approx. 23% and non-GAAP EPS of $0.47.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?